SNX3 Polyclonal Antibody

SNX3 (sorting nexin 3) encodes a member of the sorting nexin family. Members of this family contain a phox (PX) domain, which is a phosphoinositide binding domain, and are involved in intracellular trafficking. This protein does not contain a coiled coil region, like most family members. This protein interacts with phosphatidylinositol-3-phosphate, and is involved in protein trafficking. A pseudogene of SNX3 is present on the sex chromosomes. Alternative splicing results in multiple transcript variants encoding distinct isoforms.

The SNX3 Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of SNX3 protein expression in various biological samples. This antibody has been meticulously developed and rigorously validated to ensure optimal performance and accuracy in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The SNX3 Polyclonal Antibody exhibits exceptional sensitivity and specificity, enabling the precise identification and quantification of SNX3 protein levels in both normal and diseased tissues. Its polyclonal nature allows for enhanced recognition of multiple epitopes, ensuring robust and consistent results across different experimental conditions.

This antibody is produced using state-of-the-art techniques, ensuring high purity and batch-to-batch consistency. It has been extensively tested and validated to guarantee its reliability and reproducibility, providing researchers with confidence in their experimental outcomes.

The SNX3 Polyclonal Antibody is supplied in a convenient and user-friendly format, allowing for easy handling and storage. It is provided in a liquid form, ready for immediate use, eliminating the need for time-consuming reconstitution procedures.

With its exceptional performance and reliability, the SNX3 Polyclonal Antibody is an indispensable tool for researchers studying SNX3 protein function and its involvement in various cellular processes. Its versatility and accuracy make it an ideal choice for both basic research and clinical applications, facilitating a deeper understanding of SNX3 biology and its potential implications in disease mechanisms.